HELP PREVENT AND TREAT HEART, VASCULAR & METABOLIC DISORDERS.
Are You A Candidate?HELP PREVENT AND TREAT HEART, VASCULAR & METABOLIC DISORDERS.
JOIN A CLINICAL TRIAL TODAY!
The National Heart Institute’s clinical trials are open to adults with a variety of cardiovascular and metabolic disorders who meet the eligibility requirements. If you have any of these conditions, check out our clinical trials opportunities in these categories:
Coronary Vascular Disease
Learn moreCholesterol Disorders
Learn moreType II Diabetes
Learn moreObesity
Learn moreHypertension
Learn moreAs a Clinical Trial Research medical organization, NHI’s focus is on connecting patients to clinical trials — that’s why we have a moral imperative to support diversity, equity, and inclusion (DEI) initiatives that ensure clinical trial populations reflect those of the real world.
NEWS & PERSPECTIVES
The National Heart Institute (NHI) provides a collection of the latest clinical news, research, and information.
PATIENT TESTIMONIALS
I was diagnosed with cardiovascular disease in 2014 (90% blockage). Dr. Lepor performed my surgery and has been my trusted doctor ever since. Dr. Lepor explained the importance of being on the cutting edge of new medical breakthroughs and made sure that I received the best care available. Today, my health is great! Dr. Lepor is a fantastic doctor and, to me, is the best cardiologist in the world!
FREQUENTLY ASKED QUESTIONS
What is the National Heart Institute?
We are a clinical research center with world-class physician investigators and clinical research coordinators working to find better treatments for a range of cardiovascular and metabolic disorders.
Who is Dr. Norman Lepor, NHI’s Founder and Director?
Dr. Norman Lepor is a graduate of The Johns Hopkins University School of Medicine and double-boarded by the American Board of Internal Medicine for Internal Medicine and Cardiovascular Disease. He has been a Principal Investigator on over sixty clinical trials over the last twenty-five years, many of which have been published in the most prestigious peer-reviewed medical journals and have had a very positive impact on a variety of cardiovascular conditions. Dr. Lepor is joined by a group of physician sub-investigators who support the research efforts and are dedicated to improving the health of not just their patients but those around the world.
What does NHI’s coordinating staff do?
Our team is responsible for arranging patient research visits, gathering important background medical information on all research participants, assessing for adverse events and side effects, dispensing research medication, and ensuring that research protocols are adhered to under the direction of the physician investigators.
Why does NHI focus on cardiovascular disease?
Cardiovascular disease is the number one killer of Americans and a leader in causing disability. Most people have family or friends who have died of cardiovascular disease, suffered a heart attack or stroke, needed an amputation, or are dealing with hypertension, heart failure, arrhythmias, obesity, or diabetes. As healthcare professionals, it's critical that we find new and better treatments to treat and prevent cardiovascular disease. NHI is committed to that goal, and we have a record of getting results.
What is a clinical trial?
A clinical trial is a process to find better and safer treatments. NHI provides clinical trials for cardiovascular and metabolic diseases such as coronary artery disease, heart failure, cholesterol disorders, hypertension, arrhythmias, diabetes, chronic kidney disease, and obesity. These trials are approved by the United States Food and Drug Administration (FDA) and supervised by outside clinical research monitors and NHI investigators to help guarantee patient safety.